InsiderClue
Insiders · Profile

TANG KEVIN

10% owner at Boundless Bio · 10% owner at Fulcrum Therapeutics · Chief Executive Officer at Aurinia Pharmaceuticals · and 4 more. Filing since 22 Apr 2008. CIK 0001178579

BOLD Boundless Bio, Inc. 10% owner · 19 trades FULC Fulcrum Therapeutics, Inc. 10% owner · 5 trades AUPH Aurinia Pharmaceuticals Inc. Chief Executive Officer · 15 trades APVO Aptevo Therapeutics Inc. Exit Filing · 7 trades HRTX HERON THERAPEUTICS, INC. /DE/ Director · 20 trades BGMS Bio Green Med Solution, Inc. 10% owner · 1 trade VNDA Vanda Pharmaceuticals Inc. 10% owner · 14 trades
Company
Date
Role
Action
Shares
Amount
Of holding
BOLD Boundless Bio, Inc.
26 Aug 2026
10% owner
Sold at will
18,300
$54.35K
0.6%
BOLD Boundless Bio, Inc.
21 Jul 2026
10% owner
Bought
2,975
$7.26K
0.1%
BOLD Boundless Bio, Inc.
20 Jul 2026
10% owner
Bought
1,623
$3.96K
0.1%
FULC Fulcrum Therapeutics, Inc.
17 Jul 2026
10% owner
Bought
50,945
$179.33K
0.7%
BOLD Boundless Bio, Inc.
17 Jul 2026
10% owner
Bought
265
$646.60
0.0%
FULC Fulcrum Therapeutics, Inc.
16 Jul 2026
10% owner
Bought
116,671
$415.35K
1.7%
BOLD Boundless Bio, Inc.
16 Jul 2026
10% owner
Bought
18,491
$45.12K
0.7%
FULC Fulcrum Therapeutics, Inc.
15 Jul 2026
10% owner
Bought
107,377
$382.26K
1.6%
BOLD Boundless Bio, Inc.
15 Jul 2026
10% owner
Bought
1,600
$3.90K
0.1%
FULC Fulcrum Therapeutics, Inc.
14 Jul 2026
10% owner
Bought
129,603
$462.91K
1.9%
BOLD Boundless Bio, Inc.
14 Jul 2026
10% owner
Bought
43,878
$106.62K
1.6%
BOLD Boundless Bio, Inc.
13 Jul 2026
10% owner
Bought
48,211
$116.67K
1.8%
FULC Fulcrum Therapeutics, Inc.
13 Jul 2026
10% owner
Bought
12,966
$45.90K
0.2%
BOLD Boundless Bio, Inc.
10 Jul 2026
10% owner
Bought
43,367
$105.38K
1.6%
BOLD Boundless Bio, Inc.
9 Jul 2026
10% owner
Bought
7
$17.36
0.0%
BOLD Boundless Bio, Inc.
8 Jul 2026
10% owner
Bought
14,338
$35.27K
0.5%
BOLD Boundless Bio, Inc.
7 Jul 2026
10% owner
Bought
15,810
$39.21K
0.6%
BOLD Boundless Bio, Inc.
6 Jul 2026
10% owner
Bought
27,062
$67.38K
1.0%
BOLD Boundless Bio, Inc.
2 Jul 2026
10% owner
Bought
9,821
$24.45K
0.4%
BOLD Boundless Bio, Inc.
1 Jul 2026
10% owner
Bought
71,612
$178.31K
2.8%
BOLD Boundless Bio, Inc.
30 Jun 2026
10% owner
Bought
26,030
$66.11K
1.0%
BOLD Boundless Bio, Inc.
29 Jun 2026
10% owner
Bought
64,762
$159.97K
2.6%
BOLD Boundless Bio, Inc.
26 Jun 2026
10% owner
Bought
75,181
$191.71K
3.1%
BOLD Boundless Bio, Inc.
25 Jun 2026
10% owner
Bought
146,390
$363.09K
6.5%
AUPH Aurinia Pharmaceuticals Inc.
2 Jun 2026
Chief Executive Officer
Bought
206,005
$3.15M
1.6%
AUPH Aurinia Pharmaceuticals Inc.
1 Jun 2026
Chief Executive Officer
Bought
343,620
$5.25M
2.8%
AUPH Aurinia Pharmaceuticals Inc.
29 May 2026
Chief Executive Officer
Bought
264,981
$4.06M
2.2%
AUPH Aurinia Pharmaceuticals Inc.
3 Mar 2026
Director
Bought
184,208
$2.62M
1.5%
AUPH Aurinia Pharmaceuticals Inc.
2 Mar 2026
Director
Bought
199,353
$2.84M
1.7%
AUPH Aurinia Pharmaceuticals Inc.
27 Feb 2026
Director
Bought
516,439
$7.23M
4.6%
AUPH Aurinia Pharmaceuticals Inc.
5 Aug 2025
Director
Bought
200,000
$2.34M
1.8%
AUPH Aurinia Pharmaceuticals Inc.
4 Aug 2025
Director
Bought
100,000
$1.13M
0.9%
AUPH Aurinia Pharmaceuticals Inc.
1 Aug 2025
Director
Bought
1,000,000
$10.12M
10.0%
AUPH Aurinia Pharmaceuticals Inc.
4 Mar 2025
Director
Bought
748,038
$5.95M
8.1%
AUPH Aurinia Pharmaceuticals Inc.
3 Mar 2025
Director
Bought
452,682
$3.63M
5.1%
AUPH Aurinia Pharmaceuticals Inc.
28 Feb 2025
Director
Bought
399,280
$3.13M
4.7%
AUPH Aurinia Pharmaceuticals Inc.
9 Dec 2024
Director
Bought
500,000
$4.55M
6.3%
AUPH Aurinia Pharmaceuticals Inc.
6 Dec 2024
Director
Bought
400,000
$3.60M
5.3%
AUPH Aurinia Pharmaceuticals Inc.
5 Dec 2024
Director
Bought
300,000
$2.67M
4.1%
APVO Aptevo Therapeutics Inc.
23 Nov 2021
Exit Filing
Sold, plan not stated
921,336
$10.37M
100%
APVO Aptevo Therapeutics Inc.
22 Nov 2021
10% owner
Sold, plan not stated
255,331
$1.80M
21.7%
APVO Aptevo Therapeutics Inc.
19 Nov 2021
10% owner
Sold, plan not stated
213,800
$1.62M
15.4%
APVO Aptevo Therapeutics Inc.
18 Nov 2021
10% owner
Sold, plan not stated
369,533
$3.08M
21.0%
APVO Aptevo Therapeutics Inc.
6 Nov 2020
10% owner
Bought
174,277
$3.96M
11.0%
APVO Aptevo Therapeutics Inc.
5 Nov 2020
10% owner
Bought
625,723
$11.75M
65.2%
APVO Aptevo Therapeutics Inc.
4 Nov 2020
10% owner
Bought
636,675
$9.14M
197%
HRTX HERON THERAPEUTICS, INC. /DE/
4 Oct 2019
Director
Bought
285,714
$5.00M
5.2%
HRTX HERON THERAPEUTICS, INC. /DE/
12 Sep 2018
Director
Sold, plan not stated
2,695,000
$96.35M
31.6%
HRTX HERON THERAPEUTICS, INC. /DE/
29 Mar 2018
Director
Bought
192,308
$5.00M
2.3%
BGMS Bio Green Med Solution, Inc.
23 Feb 2017
10% owner
Bought
134,200
$582.08K
31.5%
HRTX HERON THERAPEUTICS, INC. /DE/
19 Jan 2017
Director
Bought
2,459,016
$30.00M
41.9%
HRTX HERON THERAPEUTICS, INC. /DE/
10 Jun 2015
Director
Bought
121,212
$3.00M
2.6%
HRTX HERON THERAPEUTICS, INC. /DE/
2 Jun 2015
Director
Bought
32,395
$772.29K
0.7%
HRTX HERON THERAPEUTICS, INC. /DE/
1 Jun 2015
Director
Bought
2,380
$45.93K
0.1%
HRTX HERON THERAPEUTICS, INC. /DE/
29 May 2015
Director
Bought
115,225
$2.27M
2.5%
HRTX HERON THERAPEUTICS, INC. /DE/
25 Jun 2014
Director
Bought
510,638
$6.00M
12.5%
VNDA Vanda Pharmaceuticals Inc.
14 Jan 2010
10% owner
Sold, plan not stated
54,900
$589.18K
2.0%
VNDA Vanda Pharmaceuticals Inc.
13 Jan 2010
10% owner
Sold, plan not stated
86,500
$912.06K
3.0%
VNDA Vanda Pharmaceuticals Inc.
12 Jan 2010
10% owner
Sold, plan not stated
27,419
$298.31K
1.0%
VNDA Vanda Pharmaceuticals Inc.
11 Jan 2010
10% owner
Sold, plan not stated
35,681
$392.64K
1.2%
VNDA Vanda Pharmaceuticals Inc.
5 Jan 2010
10% owner
Sold, plan not stated
45,500
$522.26K
1.5%
VNDA Vanda Pharmaceuticals Inc.
4 Jan 2010
10% owner
Sold, plan not stated
100,000
$1.17M
3.3%
HRTX HERON THERAPEUTICS, INC. /DE/
19 Oct 2009
Director
Bought
2,443,181
$2.15M
30.6%
VNDA Vanda Pharmaceuticals Inc.
15 Oct 2009
10% owner
Sold, plan not stated
57,928
$683.78K
1.9%
VNDA Vanda Pharmaceuticals Inc.
13 Oct 2009
10% owner
Sold, plan not stated
542,072
$6.92M
14.8%
HRTX HERON THERAPEUTICS, INC. /DE/
31 Dec 2008
10% owner
Bought
175,000
$72.63K
2.2%
HRTX HERON THERAPEUTICS, INC. /DE/
18 Dec 2008
10% owner
Bought
415,300
$200.67K
5.6%
VNDA Vanda Pharmaceuticals Inc.
20 Nov 2008
10% owner
Bought
145,000
$105.53K
4.1%
HRTX HERON THERAPEUTICS, INC. /DE/
13 Nov 2008
10% owner
Bought
841,032
$404.72K
12.8%
VNDA Vanda Pharmaceuticals Inc.
7 Nov 2008
10% owner
Bought
560,000
$464.30K
18.9%
HRTX HERON THERAPEUTICS, INC. /DE/
31 Oct 2008
10% owner
Bought
336,300
$204.07K
5.4%
HRTX HERON THERAPEUTICS, INC. /DE/
10 Oct 2008
10% owner
Bought
870,000
$647.02K
16.2%
HRTX HERON THERAPEUTICS, INC. /DE/
30 Sep 2008
10% owner
Bought
650,000
$627.90K
13.8%
VNDA Vanda Pharmaceuticals Inc.
25 Sep 2008
10% owner
Bought
600,000
$622.68K
12.0%
VNDA Vanda Pharmaceuticals Inc.
23 Sep 2008
10% owner
Bought
80,000
$78.52K
1.6%
VNDA Vanda Pharmaceuticals Inc.
22 Sep 2008
10% owner
Bought
100,000
$99.88K
2.1%
VNDA Vanda Pharmaceuticals Inc.
19 Sep 2008
10% owner
Bought
1,080,852
$1.06M
28.8%
HRTX HERON THERAPEUTICS, INC. /DE/
25 Apr 2008
10% owner
Bought
5,236
$5.24K
0.1%
HRTX HERON THERAPEUTICS, INC. /DE/
24 Apr 2008
10% owner
Bought
10,160
$10.16K
0.2%
HRTX HERON THERAPEUTICS, INC. /DE/
23 Apr 2008
10% owner
Bought
300
$300.00
0.0%
HRTX HERON THERAPEUTICS, INC. /DE/
22 Apr 2008
10% owner
Bought
685,612
$685.60K
17.1%
81 decisions on file.